Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth L Siegler

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Molecular Therapy Oncolytics|April 5, 2021
<i>In vivo</i> CART cell imaging: Paving the way for success in CART cell therapyReona Sakemura, Ismail Can, Elizabeth L Siegler, et al.
Iscience|April 24, 2020
ERK Activation in CAR T Cells Is Amplified by CD28-Mediated Increase in CD3ζ PhosphorylationJennifer A Rohrs, Elizabeth L Siegler, Pin Wang, et al.
Experimental Hematology|February 12, 2022
Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learnedIsmail Can, Michelle J Cox, Elizabeth L Siegler, et al.
Leukemia & Lymphoma|March 8, 2021
Resistance to CART cell therapy: lessons learned from the treatment of hematological malignanciesReona Sakemura, Michelle J Cox, Mehrdad Hefazi, et al.
Molecular Therapy Oncolytics|April 18, 2022
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunitiesLionel A Kankeu Fonkoua, Olivia Sirpilla, Reona Sakemura, et al.
Frontiers in Pediatrics|January 29, 2024
Treatment strategies for relapse after CAR T-cell therapy in B cell lymphomaShuto Negishi, James H Girsch, Elizabeth L Siegler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2017
Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug CarriersElizabeth L Siegler, Yu Jeong Kim, Xianhui Chen, et al.
Advanced Healthcare Materials|February 9, 2019
Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor ModelYuta Ando, Elizabeth L Siegler, Hoang P Ta, et al.
Journal of Visualized Experiments : Jove|February 27, 2023
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse ModelClaudia Manriquez Roman, R Leo Sakemura, Brooke L Kimball, et al.
Journal of Visualized Experiments : Jove|March 7, 2022
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed TomographyReona Sakemura, Michelle J Cox, Aditya Bansal, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Molecular Therapy Oncolytics|April 5, 2021
<i>In vivo</i> CART cell imaging: Paving the way for success in CART cell therapyReona Sakemura, Ismail Can, Elizabeth L Siegler, et al.
Iscience|April 24, 2020
ERK Activation in CAR T Cells Is Amplified by CD28-Mediated Increase in CD3ζ PhosphorylationJennifer A Rohrs, Elizabeth L Siegler, Pin Wang, et al.
Experimental Hematology|February 12, 2022
Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learnedIsmail Can, Michelle J Cox, Elizabeth L Siegler, et al.
Leukemia & Lymphoma|March 8, 2021
Resistance to CART cell therapy: lessons learned from the treatment of hematological malignanciesReona Sakemura, Michelle J Cox, Mehrdad Hefazi, et al.
Molecular Therapy Oncolytics|April 18, 2022
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunitiesLionel A Kankeu Fonkoua, Olivia Sirpilla, Reona Sakemura, et al.
Frontiers in Pediatrics|January 29, 2024
Treatment strategies for relapse after CAR T-cell therapy in B cell lymphomaShuto Negishi, James H Girsch, Elizabeth L Siegler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2017
Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug CarriersElizabeth L Siegler, Yu Jeong Kim, Xianhui Chen, et al.
Advanced Healthcare Materials|February 9, 2019
Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor ModelYuta Ando, Elizabeth L Siegler, Hoang P Ta, et al.
Journal of Visualized Experiments : Jove|February 27, 2023
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse ModelClaudia Manriquez Roman, R Leo Sakemura, Brooke L Kimball, et al.
Journal of Visualized Experiments : Jove|March 7, 2022
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed TomographyReona Sakemura, Michelle J Cox, Aditya Bansal, et al.
Pageof 4